Tokyo, Japan

Izumi Ide

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Cyfuse Biomedical K.k.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Izumi Ide. Retrieved from https://idiyas.com/inventor/izumi-ide

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Izumi Ide in Hepatotoxicity Evaluation

Introduction

Izumi Ide is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biomedical engineering, particularly in the development of human liver-like structures for toxicity evaluation.

Latest Patents

Izumi Ide holds a patent for a "Human liver-like three-dimensional structure, method for evaluating hepatotoxicity and human liver-like complex." This innovative construct allows for accurate and simple evaluation of human-specific toxicity. The invention features a human liver-like three-dimensional construct comprising a heterospheroid, which aggregates human hepatic cells with other human-derived cells that are not hepatic. The design is characterized by a specific ratio of these cells, enhancing the reliability of toxicity assessments.

Career Highlights

Izumi Ide is associated with Cyfuse Biomedical K.K., a company focused on advancing biomedical technologies. His work has been instrumental in bridging the gap between laboratory research and practical applications in human health.

Collaborations

Izumi Ide collaborates with notable colleagues, including Toshihiko Maekawa and Eri Nagao, who contribute to the innovative projects at Cyfuse Biomedical K.K. Their combined expertise fosters a dynamic research environment.

Conclusion

Izumi Ide's contributions to the field of hepatotoxicity evaluation through his innovative patent exemplify the potential of biomedical engineering to improve human health assessments. His work continues to pave the way for advancements in toxicity evaluation methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…